Candida auris (C. auris) is a type of fungus that can cause severe infections, particularly in people with weakened immune systems. First identified in 2009 in Japan, it has since been reported in over 30 countries.
The Centers for Disease Control and Prevention (CDC) has labeled it as an emerging global threat due to its ability to rapidly spread in healthcare facilities.
Transmission
C. auris can be spread through healthcare facilities, particularly in intensive care units and long-term care facilities. It can survive on surfaces for long periods and easily be transferred by healthcare personnel or contaminated equipment.
The fungus can also spread through contact with an infected person’s skin, and in some cases, it may be present on healthy individuals without causing an infection. People carrying the fungus are at a higher risk of developing an infection if they have certain underlying health conditions, such as diabetes or a weakened immune system.
Symptoms
C. auris can cause a wide range of symptoms, depending on which part of the body is infected. It most commonly causes bloodstream infections, which can lead to sepsis.
Other infections may include wound infections, urinary tract infections, and ear infections. Symptoms of an infection may include fever, chills, and fatigue.
Diagnosis
Diagnosing C. auris can be challenging since it is often resistant to many antifungal medications. Doctors may use blood tests, urine tests, or other cultures to identify the fungus.
It is essential to inform healthcare providers if you have recently traveled to an area where C. auris outbreaks have occurred or been in contact with someone who has been infected.
Treatment
C. auris is resistant to multiple antifungal medications, which can make treating it particularly challenging. Doctors may need to use a combination of drugs or higher doses to combat the infection.
Patients who are infected may need to be hospitalized and receive intravenous (IV) medication.
Prevention
Preventing the spread of C. auris requires strict infection control measures, such as proper hand hygiene and cleaning of surfaces and equipment in healthcare facilities. Infected individuals may be isolated to prevent further spread.
Healthcare providers should be aware of the risk of C. auris and take measures to prevent its spread. Additionally, individuals with weakened immune systems should take steps to avoid exposure to the fungus.
Outlook
C. auris is a concerning global health threat due to its ability to spread rapidly and its resistance to many antifungal medications.
It is essential to take steps to prevent the spread of this fungus and be aware of the symptoms and risk factors associated with infection.
Conclusion
C. auris is a relatively new and concerning global health threat that can cause severe infections in people with weakened immune systems. Preventing its spread requires strict infection control measures and awareness of the risk factors for infection.
Doctors may need to use a combination of drugs or higher doses to treat infected individuals, and research is ongoing to better understand this emerging fungus.